- Home
- USB vs BDX Comparison
USB vs BDX Comparison
Compare USB & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USB
- BDX
- Stock Information
- Founded
- USB 1863
- BDX 1897
- Country
- USB United States
- BDX United States
- Employees
- USB N/A
- BDX N/A
- Industry
- USB Major Banks
- BDX Medical/Dental Instruments
- Sector
- USB Finance
- BDX Health Care
- Exchange
- USB Nasdaq
- BDX Nasdaq
- Market Cap
- USB 76.2B
- BDX 66.1B
- IPO Year
- USB N/A
- BDX 1962
- Fundamental
- Price
- USB $48.32
- BDX $237.34
- Analyst Decision
- USB Buy
- BDX Strong Buy
- Analyst Count
- USB 20
- BDX 6
- Target Price
- USB $53.98
- BDX $283.50
- AVG Volume (30 Days)
- USB 8.5M
- BDX 2.0M
- Earning Date
- USB 01-16-2025
- BDX 02-06-2025
- Dividend Yield
- USB 4.14%
- BDX 1.75%
- EPS Growth
- USB 15.84
- BDX 18.61
- EPS
- USB 3.79
- BDX 5.86
- Revenue
- USB $25,097,000,000.00
- BDX $20,178,000,000.00
- Revenue This Year
- USB N/A
- BDX $10.12
- Revenue Next Year
- USB $4.33
- BDX $5.02
- P/E Ratio
- USB $12.77
- BDX $40.51
- Revenue Growth
- USB N/A
- BDX 4.16
- 52 Week Low
- USB $37.81
- BDX $218.75
- 52 Week High
- USB $53.98
- BDX $248.42
- Technical
- Relative Strength Index (RSI)
- USB 46.02
- BDX 65.01
- Support Level
- USB $47.20
- BDX $227.66
- Resistance Level
- USB $51.12
- BDX $238.00
- Average True Range (ATR)
- USB 1.00
- BDX 4.69
- MACD
- USB 0.10
- BDX 0.83
- Stochastic Oscillator
- USB 31.20
- BDX 91.61
About USB U.S. Bancorp
With assets of around $680 billion, U.S. Bancorp is one of the largest regional banks in the us with its footprint in 26 states. The bank's branch network is mostly in the midwestern and western markets. U.S. Bancorp has a comprehensive product set, with offerings in retail and commercial banking, credit cards, mortgages, payment services, trust, and wealth services.
About BDX Becton Dickinson and Company
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.